Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-04-10

Clinical Trial Update: Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial [EARLY_Phase 1]

View source ↗

Summary

A randomized Phase 1 trial reports results on whether inositol therapy affects cardiovascular risk in women with polycystic ovary syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inositol (inositol)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Polycystic Ovary Syndrome | EARLY_Phase 1 | Status: UNKNOWN